Victoza – Diabetes Health

Diabetes Health in The News Podcast: FDA Approves Novo Nordisk’s Type 2 Diabetes Drug for Young Patients

June 26, 2019June 23, 2019 Nadia 0 Comments

There’s a new treatment for Type 2 diabetes that may be perfect for children. The FDA has recently approved Victoza injections as a treatment option to help lower blood sugar in children and adolescents aged 10-17. Designed to be used alongside exercise and diet, Victoza has been on the market since 2010 but was approved specifically for younger patients this year. This offers an additional

Astrazeneca Bydureon Diabetes Diabetes Health Diabetes Health Magazine Diabetes Support Diabetic Medicine News Type 1 Victoza

Once-Weekly Tanzeum for Type 2s Now Available

September 9, 2014 Nadia 0 Comments

Tanzeum (albiglutide), a once-weekly injectable drug for type 2s from GSK (GlaxoSmithKline), USA is now available at pharmacies throughout the United States. The FDA approved U.S. sales on April 15. The drug is a glucagon-like peptide-1 receptor agonist (GLP-1) that can be used in conjunction with other type 2 drugs. GLP-1s work by inducing the pancreas to produce more insulin when blood sugar levels begin

A1c Diabetes Diabetes Health Diabetes Health Magazine Diabetes Medicine Hypoglycemia Living With Diabetes News Novo Nordisk Victoza

Weekly Dulaglutide Performs Well in Comparison to Daily Liraglutide

August 1, 2014 Nadia 0 Comments

A comparison of the effects on A1c between users of once-weekly dulaglutide (made by Eli Lilly and Company) and once-daily liraglutide (sold as Victoza from Novo Nordisk) shows that both drugs have very similar effects. Researchers at Ohio State University conducted a nine-country study of 599 type 2 patients, aged 18 years and older, with A1c’s between 7% and 10%, and taking at least 1,500

Blog Diet Medication Novo Nordisk Type 2 Victoza

NBA Hall of Famer Dominique Wilkins: Has A Slam Dunk Formula for Diabetes

June 30, 2014March 27, 2019 Nadia 0 Comments

NBA Hall of Famer Dominique Wilkins, affectionately known as “The Human Highlight Film” has a few coaching tips for people with diabetes. Several years after retiring from the Atlanta Hawks, Dominique was diagnosed with type 2 diabetes. Once he stopped playing professional basketball, he stopped exercising and eating well. Consequently, he started experiencing some common diabetes symptoms, blurry vision and frequent urination. Diabetes was not

Blog Bydureon Byetta Fda Januvia Merck Novo Nordisk Victoza

FDA Backtracks Over GLP-1s’ Effects on Pancreas

March 4, 2014 Nadia 0 Comments

The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a link between GLP-1 drugs used to treat type 2 diabetes and pancreatic maladies, including acute pancreatitis and pancreatic cancer. GLP-1 drugs, which work by stimulating the body to produce insulin, include Bristol-Myers Squibb’s Byetta and Bydureon, Merck’s Januvia and Janumet, and Novo Nordisk’s Victoza. However,

Bydureon Byetta Exenatide Glp-1 News Novo Nordisk Type 2 Victoza

Weekly Type 2 Drug to Be Delivered Via Needle Patch

February 24, 2014 Nadia 0 Comments

A recent agreement between Zosano Pharma, Inc. and Novo Nordisk could lead to the introduction of a once-weekly drug for type 2s that is administered via a micro-needle patch system. The drug, now under development by Novo Nordisk, is semaglutide, a GLP-1 (glucagon-like peptide) receptor agonist that the company is hoping to introduce as a one-a-week therapy. GLP-1s stimulate the release of insulin while also

Byetta Dpp-4 Inhibitors Invokana Januvia News Victoza

First-World Type 2 Drug Market to Reach $47 Billion by 2022

October 18, 2013 Nadia 0 Comments

A Massachusetts-based research firm concludes that the first-world market for type 2 drugs and treatments will increase from $27 billion in sales in 2012 to $47 billion in 2022. The firm, Decision Resources, says increased sales in the United States, Japan, France, Germany, Italy, Spain, and the United Kingdom, will come from both an increase in the type 2 patient population and the introduction of

A1c Byetta Diabetes Diabetes Health Diabetes Health Magazine Diabetic Fda Insulin Merck Metformin News Research Type 2 Issues Victoza

Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs

November 20, 2012 Nadia 0 Comments

Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies. According to Lilly, dulaglutide, a GLP-1 analog, worked better to reduce A1c levels than metformin, Merck & Co.’s Januvia (sitagliptin),

Blog Celebrities Diet Novo Nordisk Recipe Victoza

Diabetes Health Type 2: Paula Deen: Cooking Up a New Life With Diabetes

August 28, 2012 Nadia 0 Comments Exercise type 2 diabetes

Paula Deen, a celebrity Southern chef known for her unrestrained love of butter and sugar, is no stranger to the media. She received a flurry of bad press recently when she revealed that she had been diagnosed with type 2 diabetes three years earlier. Shortly thereafter, she became a spokesperson for Novo Nordisk’s Victoza. Following these developments, some critics said that she was a poor

Blog Blood Sugars Bydureon Byetta Diabetes Glp-1 Januvia Metformin Neuropathy Victoza

Am I Doing the Right Thing?

March 29, 2012 Nadia 0 Comments

Readers occasionally ask us for advice about drugs they are taking. When they do, we refer their questions to a medical professional. In the question below, a Florida reader expresses concerns about the interaction of her diabetes drug with the medicines she takes for asthma. Dear Diabetes Health: I am asthmatic and was diagnosed with diabetes two or three years ago. I am 61 and

← Previous